LLY

765.61

+0.24%↑

JNJ

175.55

-0.76%↓

ABBV

220.25

-0.19%↓

UNH

340.14

-0.01%↓

AZN

76.65

-1.34%↓

LLY

765.61

+0.24%↑

JNJ

175.55

-0.76%↓

ABBV

220.25

-0.19%↓

UNH

340.14

-0.01%↓

AZN

76.65

-1.34%↓

LLY

765.61

+0.24%↑

JNJ

175.55

-0.76%↓

ABBV

220.25

-0.19%↓

UNH

340.14

-0.01%↓

AZN

76.65

-1.34%↓

LLY

765.61

+0.24%↑

JNJ

175.55

-0.76%↓

ABBV

220.25

-0.19%↓

UNH

340.14

-0.01%↓

AZN

76.65

-1.34%↓

LLY

765.61

+0.24%↑

JNJ

175.55

-0.76%↓

ABBV

220.25

-0.19%↓

UNH

340.14

-0.01%↓

AZN

76.65

-1.34%↓

Search

Repligen Corp

Avatud

SektorTervishoid

123.43 2.14

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

116.72

Max

125.53

Põhinäitajad

By Trading Economics

Sissetulek

9M

15M

Müük

13M

182M

P/E

Sektori keskmine

466.89

35.293

Kasumimarginaal

8.152

Töötajad

1,778

EBITDA

7.7M

44M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+46.97% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

11. nov 2025

Turustatistika

By TradingEconomics

Turukapital

-324M

6.4B

Eelmine avamishind

121.29

Eelmine sulgemishind

123.43

Uudiste sentiment

By Acuity

73%

27%

339 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Repligen Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. sept 2025, 23:01 UTC

Omandamised, ülevõtmised, äriostud

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid -- Update

17. sept 2025, 22:48 UTC

Omandamised, ülevõtmised, äriostud

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid

17. sept 2025, 21:59 UTC

Tulu

Cryptocurrency-Exchange Bullish Swings to Profit in First Report as Public Company

17. sept 2025, 23:44 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

17. sept 2025, 23:39 UTC

Market Talk

Gold Rises Amid Prospects of Further Fed Rate Cuts -- Market Talk

17. sept 2025, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Santos: XRG Consortium Wouldn't Agree to Appropriate Risk Allocation Between It and Santos Shareholders

17. sept 2025, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Santos: XRG Consortium Wouldn't Agree to Acceptable Terms That Protected Value of Transaction

17. sept 2025, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Santos Had Expressed Concern to XRG Consortium About Delays in Agreeing to Scheme Implementation Agreement

17. sept 2025, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Santos: Consortium Notified Board of Decision to Withdraw Proposal on Weds Evening

17. sept 2025, 22:18 UTC

Omandamised, ülevõtmised, äriostud

Santos Confirms XRG Consortium Has Withdrawn Takeover Proposal

17. sept 2025, 21:00 UTC

Tulu

Darden Restaurants to Report Earnings. Why the Olive Garden Parent Is Expected to Stay Strong. -- Barrons.com

17. sept 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

17. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. sept 2025, 19:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. sept 2025, 19:59 UTC

Market Talk

Treasury Yields, Dollar Rise as Fed Cuts, Powell Warns of Risks -- Market Talk

17. sept 2025, 19:07 UTC

Market Talk

Oil Futures Snap Three-Session Winning Streak -- Market Talk

17. sept 2025, 18:43 UTC

Market Talk

Treasury Yields, Dollar Reverse Course as Powell Talks to Reporters -- Market Talk

17. sept 2025, 18:38 UTC

Market Talk

U.S. Natural Gas Futures Mixed Ahead of Storage Data -- Market Talk

17. sept 2025, 18:20 UTC

Market Talk

Gold Dips After Quarter-Point Rate Cut -- Market Talk

17. sept 2025, 18:18 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. sept 2025, 18:18 UTC

Market Talk

Treasury Yields, Dollar Fall on Nearly Unanimous Fed Cut -- Market Talk

17. sept 2025, 18:14 UTC

Market Talk

Oil Slips Some More as Fed Makes Expected 25 Bp Rate Cut -- Market Talk

17. sept 2025, 17:59 UTC

Market Talk

Soyoil Takes Hit as Traders Consider EPA Proposal -- Market Talk

17. sept 2025, 17:15 UTC

Omandamised, ülevõtmised, äriostud

Netflix 'Has Won The Streaming Wars,' Analyst Says. The Stock Is a Buy. -- Barrons.com

17. sept 2025, 17:06 UTC

Omandamised, ülevõtmised, äriostud

Walmart Stock Heads for a Record High. The Retailer Could Become a Leader in 'Agentic' AI. -- Barrons.com

17. sept 2025, 16:51 UTC

Tulu

Correct: Exor 1H Net Loss -EUR624M

17. sept 2025, 16:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. sept 2025, 16:34 UTC

Market Talk

Bank of Canada Ditches Resilience Talk, Plays Up Slowing Growth -- Market Talk

17. sept 2025, 16:25 UTC

Tulu

Wolters Kluwer: July, August Saw a Slight Increase in Organic Growth Compared to 1H

17. sept 2025, 16:23 UTC

Tulu

Wolters Kluwer: Year-to-Date Performance In Line With 2025 Guidance

Võrdlus sarnastega

Hinnamuutus

Repligen Corp Prognoos

Hinnasiht

By TipRanks

46.97% tõus

12 kuu keskmine prognoos

Keskmine 176 USD  46.97%

Kõrge 220 USD

Madal 130 USD

Põhineb 14 Wall Streeti analüütiku instrumendi Repligen Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

14 ratings

11

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

125.31 / 140.7Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Strong Bearish Evidence

Sentiment

By Acuity

339 / 371 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat